Harnessing mobile devices to create a sustainable way of delivering eye care at scale, through COVID and beyond

利用移动设备创建一种可持续的方式，在新冠疫情及其他情况下大规模提供眼部护理

• 批准号: 77525
• 金额: $ 20.75万
• 依托单位: OKULO LTD
• 依托单位国家: 英国
• 项目类别: Collaborative R&D
• 财政年份: 2020
• 资助国家: 英国
• 起止时间: 2020 至 无数据
• 项目状态: 已结题
• 来源: https://gtr.ukri.org/projects?ref=77525
• 关键词: Harnessing; mobile; devices; create; sustainable

Okulo Ltd (trading as OKKO Health) develop smartphone software for home-monitoring of vision.This project is to drive the development of a technological system and corresponding patient pathway to allow AI-driven home-monitoring of vision for patients who would otherwise have had to come for in-person hospital eye clinic appointments. This project will develop diagnostic biomarkers from app data and research ways to optimise their uptake in the NHS and beyond. This will increase both the environmental sustainability and the financial sustainability of the NHS.This responds to the acute COVID challenge that we now need to triage/monitor vision away from hospital clinics. The mass cancellation of in-person appointments means that our patient population face sight loss if a deterioration in their condition is not picked up early enough in time for treatment.In the project we will work closely with NHS units and with University of Bristol staff. The proposed project isn't just about developing connected and clever technology, but it's about co-designing with patients and their families, and doctors, nurses and hospital administration systems a brand new digital pathway of care that will revolutionise the experience of eye care for all of us when we need it.

Okulo Ltd（交易名称为OKKO Health）开发用于家庭视力监测的智能手机软件。该项目旨在推动技术系统和相应患者路径的开发，以允许人工智能驱动的家庭视力监测，否则患者必须亲自前往医院眼科诊所预约。该项目将从应用程序数据和研究方法中开发诊断生物标志物，以优化其在NHS及其他领域的吸收。这将提高NHS的环境可持续性和财务可持续性。这是对我们现在需要从医院诊所分流/监测视力的急性COVID挑战的回应。大规模取消面对面预约意味着我们的患者群体面临视力丧失，如果他们的病情恶化没有及时及时得到治疗。在该项目中，我们将与NHS单位和布里斯托大学的工作人员密切合作。拟议的项目不仅仅是开发连接和智能技术，而是与患者及其家属，医生，护士和医院管理系统共同设计一种全新的数字护理途径，这将在我们需要时彻底改变我们所有人的眼科护理体验。